(Q38050063)

27 August 2017

title

Targeting and delivery of platinum-based anticancer drugs (English)

1 reference

27 August 2017

1 reference

Xiaoyong Wang

1

0 references

author name string

Zijian Guo

series ordinal

2

1 reference

27 August 2017

publication date

5 October 2012

1 reference

27 August 2017

published in

Chemical Society Reviews

1 reference

27 August 2017

volume

42

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

202-224

1 reference

The resurgence of platinum-based cancer chemotherapy

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Metal based drugs: from serendipity to design

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Molecular mechanisms of resistance and toxicity associated with platinating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

A review on oxaliplatin-induced peripheral nerve damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Platinum neurotoxicity pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Cisplatin nephrotoxicity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Resistance against novel anticancer metal compounds: differences and similarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Mechanisms of resistance to cisplatin and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Metallothioneins and platinum(II) anti-tumor compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

The role of sulfur in platinum anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Platinum resistance: the role of DNA repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Signalling cell cycle arrest and cell death through the MMR System

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Molecular mechanisms of cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Anticancer metallotherapeutics in preclinical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Platinum complexes as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

The rational design of anticancer platinum complexes: the importance of the structure-activity relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

The status of platinum anticancer drugs in the clinic and in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Antitumour metal compounds: more than theme and variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Fresh platinum complexes with promising antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Basis for design and development of platinum(IV) anticancer complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Anticancer platinum (IV) prodrugs with novel modes of activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Recent developments in the field of anticancer platinum complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Direct cellular responses to platinum-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Cisplatin cytotoxicity: DNA and plasma membrane targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Current status and future prospects for satraplatin, an oral platinum analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Platinum drug distribution in cancer cells and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Platinum formulations as anticancer drugs clinical and pre-clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Drug transporters of platinum-based anticancer agents and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Paul Ehrlich's magic bullet concept: 100 years of progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

New trends for metal complexes with anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Novel and emerging approaches for the delivery of metallo-drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Strategies for optimizing combinations of molecularly targeted anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Exploiting the enhanced permeability and retention effect for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Glycolysis inhibition for anticancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

International Union of Pharmacology. LXIV. Estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

A bifunctional platinum(II) antitumor agent that forms DNA adducts with affinity for the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Synthesis of 17beta-estradiol-platinum(II) hybrid molecules showing cytotoxic activity on breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Steroid conjugates of dichloro(6-aminomethylnicotinate)platinum(II): effects on DNA, sex hormone binding globulin, the estrogen receptor, and various breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

An estrogen-platinum terpyridine conjugate: DNA and protein binding and cellular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Synthesis and cytotoxic activity of benzopyran-based platinum(II) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Carbohydrate-metal complexes and their potential as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Adamantane-platinum conjugate hosted in β-cyclodextrin: enhancing transport and cytotoxicity by noncovalent modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Supramolecular nanoencapsulation as a tool: solubilization of the anticancer drug trans-dichloro(dipyridine)platinum(II) by complexation with beta-cyclodextrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Inducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Bisphosphonate actions: physical chemistry revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Platinum(II) compounds bearing bone-targeting group: synthesis, crystal structure and antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Platinum complexes can inhibit matrix metalloproteinase activity: platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Encapsulation of platinum anticancer drugs by apoferritin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

The strategic use of supramolecular pK(a) shifts to enhance the bioavailability of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Cucurbit[n]uril binding of platinum anticancer complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Cucurbituril binding of trans-[{PtCl(NH3)2}2(micro-NH2(CH2)8NH2)]2+ and the effect on the reaction with cysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Synthesis, cytotoxicity and cucurbituril binding of triamine linked dinuclear platinum complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Improving platinum(II)-based anticancer drug delivery using cucurbit[n]urils

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

A chemical preformulation study of a host-guest complex of cucurbit[7]uril and a multinuclear platinum agent for enhanced anticancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Novel platinum(II)-based anticancer complexes and molecular hosts as their drug delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

DNA intercalators in cancer therapy: organic and inorganic drugs and their spectroscopic tools of analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Chiral platinum(II) metallointercalators with potent in vitro cytotoxic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Degradation of bidentate-coordinated platinum(II)-based DNA intercalators by reduced L-glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Encapsulation of platinum(II)-based DNA intercalators within cucurbit[6,7,8]urils

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Substituted beta-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Side-on binding of p-sulphonatocalix[4]arene to the dinuclear platinum complex trans-[{PtCl(NH3)2}2mu-dpzm]2+ and its implications for anticancer drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Synthesis and characterization of a platinum(II) complex tethered to a ligand of the peripheral benzodiazepine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Platinum(II) complexes with bioactive carrier ligands having high affinity for the translocator protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Syntheses and characterization of vitamin B12-Pt(II) conjugates and their adenosylation in an enzymatic assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Vitamin B₁₂ as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Polymer conjugates as anticancer nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Searching for the magic bullet: anticancer platinum drugs which can be accumulated or activated in the tumor tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Polymer therapeutics: concepts and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Polymeric drug delivery of platinum-based anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Polymer architecture and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Prodrug strategies in anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Nanoparticle therapeutics: an emerging treatment modality for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Recent progress in dendrimer-based nanocarriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Gum arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

ProLindac (AP5346): a review of the development of an HPMA DACH platinum Polymer Therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Phase I and pharmacokinetic trial of AP5346, a DACH-platinum-polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Mono- and polynuclear [alkylamine]platinum(II) complexes of [1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II): synthesis and investigations on cytotoxicity, cellular distribution, and DNA and protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Dinuclear alkylamine platinum(II) complexes of [1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II): influence of endocytosis and copper and organic cation transport systems on cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Polymeric micellar delivery systems in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Poly (amino acid) micelle nanocarriers in preclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Visible drug delivery by supramolecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

How we got here, where we are going and being a cog in something turning

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Activity of lipoplatin in tumor and in normal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Phase 1 trial of lipoplatin and gemcitabine as a second-line chemotherapy in patients with nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Nucleoside-lipid-based nanoparticles for cisplatin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Targeting carbon nanotubes against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Toxicity of single-walled carbon nanohorns

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

The EGF receptor family: spearheading a merger of signaling and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Nanotechnology applications in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

The emerging nanomedicine landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Nanoparticles in medicine: therapeutic applications and developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Advances and challenges of nanotechnology-based drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Therapeutic nanoparticles for drug delivery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Nanoscale coordination polymers for platinum-based anticancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Gold nanoparticles in delivery applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Gold nanoparticles for biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Gold nano-popcorn-based targeted diagnosis, nanotherapy treatment, and in situ monitoring of photothermal therapy response of prostate cancer cells using surface-enhanced Raman spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Effect of surface properties on nanoparticle-cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Cisplatin-loaded Au-Au2S nanoparticles for potential cancer therapy: cytotoxicity, in vitro carcinogenicity, and cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Oligonucleotide-modified gold nanoparticles for intracellular gene regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Nanoparticle-mediated cellular response is size-dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Gold nanorods for platinum based prodrug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Combating the drug resistance of cisplatin using a platinum prodrug based delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Magnetic nanoparticles in MR imaging and drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Magnetic nanoparticles for theragnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Modification of magnetic silica/iron oxide nanocomposites with fluorescent polymethacrylic acid for cancer targeting and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Dumbbell-like Au-Fe3O4 nanoparticles for target-specific platin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Strategies to improve the efficacy of platinum compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Polymer Therapeutics for Cancer: Current Status and Future Challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Anticancer Polymeric Nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Cisplatin-Tethered Gold Nanoparticles That Exhibit Enhanced Reproducibility, Drug Loading, and Stability: a Step Closer to Pharmaceutical Approval?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

Biomimetic Hydroxyapatite–Drug Nanocrystals as Potential Bone Substitutes with Antitumor Drug Delivery Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

The Drug Targeting and Delivery Approach Applied to Pt-Antitumour Complexes. A Coordination Point of View

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35259A

21 January 2018

Identifiers

DOI

10.1039/C2CS35259A

1 reference

27 August 2017

1 reference